发明名称 |
FAP-ACTIVATED ANTI-TUMOR COMPOUNDS |
摘要 |
The invention relates to a prodrug that is capable of being converted into a drug by the catalytic action of human fibroblast activation protein (FAP.alpha.), said prodrug is chemically stable under physiological conditions and can be used for the manufacture of physically stable aqueous formulations. It has a cleavage site which is recognised by FAP.alpha., and the drug released by the enzymatic activity of FAP.alpha. is cytotoxic or cytostatic under physiological conditions.
|
申请公布号 |
CA2472296(A1) |
申请公布日期 |
2003.08.07 |
申请号 |
CA20032472296 |
申请日期 |
2003.01.28 |
申请人 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
发明人 |
LENTER, MARTIN;PETERS, STEFAN;BLECH, STEFAN MATTHIAS;GARIN-CHESA, PILAR;PARK, JOHN EDWARD;BREITFELDER, STEFFEN |
分类号 |
A61K38/00;A61K31/704;A61K47/48;A61P35/00;C07K5/06;C07K5/097;C07K5/103;C07K5/117;C07K9/00;(IPC1-7):C07K5/06 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|